Specialty Enzymes: A Global Strategic Business Report
San Jose, California (Vocus) October 29, 2010
Specialty enzymes market that registered healthy year-over-year growth rates over the past several years, received a setback during 2008 and 2009 because of turmoil in the global economy. Decline in demand for specialty enzymes in various end-use categories including pharmaceuticals & diagnostics, and research/biotechnology, discouraged by companies cutting back on expenditure, led to noticeable drop in the market revenues during the period. However, the market is likely to recover by 2011 and is expected to post growth in the ensuing years. The projected expansion of the biocatalyst sector coupled with the ever-increasing requirements of the pharmaceutical industry is likely to drive the market. Further, advances in the engineering of enzymes using biotechnological methods and processes, whereby enzymes are being increasingly applied for specific applications, are expected to encourage the market.
Increased use of specialty enzymes in the pharmaceutical and diagnostics industry, the largest end-use segment, is expected to continue primarily driven by emergence of many new techniques and therapies, such as enzyme replacement, and innovations in thrombolytics. Another contributing element is the demand for chiral chemicals in the pharmaceutical and fine chemical fields where enzymes are used as biocatalysts. Further, newer applications including production of polyactide polymers and raw materials for polyester polytrimethylene terephthalate are projected to accelerate the enzyme demand in the coming years.
Europe represents the largest regional market for specialty enzymes worldwide, as stated by the new market research report on Specialty Enzymes. The US represents the second largest market for specialty enzymes in the world. Asia-Pacific is poised to demonstrate the fastest growth with a CAGR of more than 5.0% over the analysis period.
Specialty Medical Enzymes, comprising thrombolytics, DNases and glucocerebrosidases among others, represents the largest product segment. Other enzymes category comprising Asparaginase, Alkaline Phosphatase and Peroxidase among others is projected to demonstrate the fastest CAGR of 5.6% over the analysis period. Pharmaceuticals & Diagnostics represents the largest as well as the fastest growing end-use segment of specialty enzymes.
Various types of enzymes are employed in manufacturing food, fuel, clothes, and other products. Enzyme processes are potentially energy saving and save investments in special equipment resistant to heat, pressure or corrosion. Specialty enzymes are utilized in several medical applications and diagnostics, including testing of food products. In general, enzymes are proteins with highly specialized catalytic functions generated by all living beings. Enzymes play a vital role in numerous aspects of life and are highly important to the existence of life itself. About 3/4th of the enzyme consumption is accounted by the industrial sector primarily in food, starch processing and detergent applications.
Major players profiled in the report include Advanced Enzymes Technologies Limited, Amano Enzyme Inc., Aureozyme Inc., Biocon Ltd., Biozyme Laboratories, Codexis Inc., Danisco A/S, Genencor International Inc., Kinetic Biosystems Inc., Maxygen Inc., Novozymes A/S, Seravac Biotech (Pty) Ltd., Specialty Enzymes and Biochemicals Co., and Verenium Corporation.
The research report titled “Specialty Enzymes: A Global Strategic Business Report” announced by Global Industry Analysts, Inc. provides a comprehensive review of the specialty enzymes markets, impact of recession on the markets, product overview, recent product introductions, recent industry activity, and profiles of major/niche global as well as regional market participants. The report provides annual sales estimates and projections for specialty enzymes market for the years 2007 through 2015 for the following geographic markets – US, Canada, Japan, Europe, Asia-Pacific, the Middle East, and Latin America. Key product segments analyzed include Specialty Medical Enzymes, Polymerases, Nucleases, and Other Enzymes. Key end-use segments analyzed include Pharmaceuticals & Diagnostics, Research/Biotechnology, and Others. Also, a seven-year (2000-2006) historic analysis is provided for additional perspective.
For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Specialty_Enzymes_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1200 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Web Site http://www.StrategyR.com/